Holen Sie sich die Stockscreener-App
0.8801
13.72%
-0.1399
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
Applied Therapeutics appoints new Executive Chairman By Investing.com - Investing.com Canada
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Eastern Progress Online
Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data - Benzinga
APLT COURT REMINDER: Applied Therapeutics, Inc. Investors that Lost Money when Stock Plummeted 80% are Encouraged to Contact BFA Law (NASDAQ:APLT) - AccessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAPLT - PR Newswire
Applied Therapeutics appoints new Executive Chairman - Investing.com
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Malaysian Reserve
APPLIED THERAPEUTICS BREAKING NEWS: BFA Law Announces that - GlobeNewswire
APPLIED THERAPEUTICS BREAKING NEWS: BFA Law Announces that Applied Therapeutics, Inc. has been Sued for Securities Fraud – Investors with Losses Urged to Contact the Firm (NASDAQ:APLT) - Business Upturn
Royal Bank of Canada Issues Pessimistic Forecast for Applied Therapeutics (NASDAQ:APLT) Stock Price - MarketBeat
Applied Therapeutics, Inc. Announces Board Changes - Marketscreener.com
Applied Therapeutics CEO Shendelman Steps Down - MarketWatch
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles - TipRanks
Applied Therapeutics sees leadership shuffle, delays drug submission - Investing.com
Applied Therapeutics Appoints John H. Johnson as Executive Chairman - GlobeNewswire
Applied Therapeutics Overhauls Leadership Amid Major Setbacks in Drug Approval Journey - StockTitan
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Applied Therapeutics, Inc. - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Markets Insider
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025Contact Kaplan Fox & Kilsheimer LLP - The Globe and Mail
Class Action Filed Against Applied Therapeutics, Inc. - GlobeNewswire
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to Join – Contact - EIN News
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - PR Newswire
Applied Therapeutics, Inc Announces Chief Executive Officer Changes - Marketscreener.com
APLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit - The Malaysian Reserve
APLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT) - GlobeNewswire Inc.
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025Contact Kaplan Fox & Kilsheimer LLP - The Globe and Mail
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
APLT Stock Hits 52-Week Low at $1.01 Amid Market Challenges - Investing.com
Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Drugmaker Sued Over Optimistic Statements Before FDA Rejection - Bloomberg Law
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Galactosemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP - TipRanks
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
Franklin Resources Inc. Reduces Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics' SWOT analysis: rare disease biopharma stock faces regulatory hurdles - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - AccessWire
Applied Therapeutics' SWOT analysis: rare disease biopharma stock faces regulatory hurdles By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Reach Out - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - AccessWire
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors - Business Wire
Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors - Marketscreener.com
Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Applied Therapeutics stock hits 52-week low at $1.17 - Investing.com India
The Law Offices of Frank R. Cruz Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors - Business Wire
Applied Therapeutics stock hits 52-week low at $1.17 By Investing.com - Investing.com UK
applied therapeutics director resigns, company seeks replacement By Investing.com - Investing.com Canada
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation - AccessWire
APLT ALERT: Kaplan Fox & Kilsheimer LLP Is Investigating Applied Therapeutics, Inc. (APLT) for Potential Securities Law Violations - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation - AccessWire
APPLIED THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations - The Globe and Mail
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):